Table 3 Summary of patients with AEs and ADRs to treatment with the SQ® grass SLIT-tablet
Concomitant AIT n (%), E | No concomitant AIT n (%), E | All patients treated n (%), E | |
|---|---|---|---|
Patients | 160 | 21 | 181 |
AEs, total | 58 (36.3), 402 | 8 (38.1), 37 | 66 (36.5), 439 |
ADRs: SQ® grass SLIT-tablet | 49 (30.6), 358 | 8 (38.1), 37 | 57 (31.5), 395 |
Medical measures (no) | 39 (24.4), 294 | 5 (23.8), 33 | 44 (24.3), 327 |
Medical measures (yes) | 10 (6.3), 64 | 3 (14.3), 4 | 13 (7.2), 68 |
Severity: mild | 15 (9.4), 136 | 5 (23.8), 34 | 20 (11.0), 170 |
Moderate | 14 (8.8), 140 | 3 (14.3), 3 | 17 (9.4), 143 |
Severe | 20 (12.5), 80 | – | 20 (11.0), 80 |
Missing value | –, 2 | – | –, 2 |
SQ® grass SLIT-tablet discontinued | 12 (7.5), 25 | 1 (4.8), 2 | 13 (7.2), 27 |
ADRs: concomitant AIT | 18 (11.3), 99 | – | 18 (9.9), 99 |